Future studies in a more extensive series of patients could support the hypothesis that miRNAs’ regulation of sHLA-G expression may play a role in the prognosis of acute leukemias, indicating the potential translation of these results in clinical practice, possibly as a new prognosis marker and target for immunotherapy. The gene discussed is HLA-G; the disease is acute leukemia.